Ernexa Therapeutics Inc. (ERNA) Cash from Restructuring (2021)
Ernexa Therapeutics' (ERNA) quarterly Cash from Restructuring came in at $5.8 million in Q1 2021.
Ernexa Therapeutics Inc. (ERNA) Cash from Restructuring (2021) Analysis & Trends
Ernexa Therapeutics (ERNA) has 1 years of Cash from Restructuring data on file, last reported at $5.8 million in Q1 2021.
- Quarterly Cash from Restructuring changed N/A year-over-year to $5.8 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $5.8 million (changed N/A YoY) and the FY2021 annual result came in at $5.8 million, changed N/A from the prior year.
- Cash from Restructuring held at $5.8 million in Q1 2021.
- In the past five years, Cash from Restructuring ranged from a high of $5.8 million in Q1 2021 to a low of $5.8 million in Q1 2021.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 5.77 Mn |